Volume 20, Issue 2 (7-2006)                   Med J Islam Repub Iran 2006 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
REZVAN H, MOTALLEBI Z, JALILI M A, MOUSAVI HOSSEINI K, POURFATHOLLAH A A. SAFETY OF BLOOD AND PLASMA DERIVATIVES: PATHOGEN REDUCING TECHNOLOGIES. Med J Islam Repub Iran 2006; 20 (2) :86-92
URL: http://mjiri.iums.ac.ir/article-1-366-en.html
SAFETY OF BLOOD AND PLASMA DERIVATIVES: PATHOGEN REDUCING TECHNOLOGIES
H. REZVAN , Z. MOTALLEBI , M. A. JALILI , K. MOUSAVI HOSSEINI , A. A. POURFATHOLLAH
, hourirezvan@yahoo.com
Abstract:   (5187 Views)

   ABSTRACT

  Human blood and blood products is the source of a wide range of medicinal products used for the treatment and prevention of a variety of injuries and disease. Despite stringent routine measures and filters employed, residual pathogen infectivity remains an important challenge in the field of blood transfusion. In this article various measures and technologies that can be applied in order to reduce the residual risk are reviewed.

Keywords: Plasma derivatives ;Virus inactivation; blood borne viruses
Full-Text [PDF 134 kb]   (2023 Downloads)    
Type of Study: Original Research | Subject: Immunology
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.